Construct · 1 fields · 1 citations

biosimilar nocebo effect: a standalone construct

One name. One construct. A landmark on the map.

● anchor · a standalone construct Nearest construct by meaning·not indexed
biosimilarnocebo effect1 CONSTRUCTBiosimilar nocebo effectODINET · PHARMACY PRACTICE

A single standalone construct; nearby constructs are located against it in the Collider. Tap a field for its definition, unit, and measures.

Pharmacy practice

worse subjective outcomes or discontinuation after switching to a biosimilar that arise from negative expectations rather than the product itself.

In pharmacy practice, biosimilar nocebo effect refers to worse subjective outcomes or discontinuation after switching to a biosimilar that arise from negative expectations rather than the product itself. This meaning comes from Odinet (2018) in Journal of Managed Care & Specialty Pharmacy.[1]

Unit
Recovery means
Measured by

Next

Run it through the Collider, or take the citations with you.

See how biosimilar nocebo effect sits against neighbouring constructs in the Collider, or export every reference on this page in one click.

Open in ColliderExport BibTeXReport this entry

Nearby constructs

nocebo effect1 fields · 4 citationsanchor · a standalone constructpractice3 fields · 4 citationsjingle · one word, three constructsproduct3 fields · 3 citationsjingle · one word, three constructs

References

  1. Odinet, J. S., Day, C. E., Cruz, J. L., & Heindel, G. A. (2018). The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies. Journal of Managed Care & Specialty Pharmacy, 24(10), 952-959. https://doi.org/10.18553/jmcp.2018.24.10.952

Cited on this page?

Confirm your construct, or correct us.

If your work is cited behind one of these entries, you know better than we do whether we captured the meaning right. Confirm it, suggest an edit, or dispute it, and your name goes on the entry as an author who has checked it, linked to your ORCID.

Claim your construct